AgeX Therapeutics, Inc. (AGE)

Operating Cash Flow

-$21.14M

TTM · Period ending: · USD

AGE logo

AGE Operating Cash Flow

Latest reported-$21.14M
AGE TTM Operating Cash Flow (-$8.00M → -$21.14M)
High-resolution chart · PNG

AGE operating cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Operating Cash Flow — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (USD)
-21,135,000
-18,201,000
-17,955,000
-23,566,000
-28,635,000
-24,885,000
-22,140,000
-12,548,000
-5,493,000
-7,512,000
-7,800,000
-7,069,000
-6,441,000
-6,168,000
-5,939,000
-6,265,000
-6,913,000
-6,861,000
-7,855,000
-7,828,000
-7,833,000
-8,383,000
-7,817,000
-8,608,000
-9,091,000
-9,606,000
-10,160,000
-9,795,000
-9,206,000
-8,608,000
-7,995,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.